Overdiagnosis of Breast Cancer
Deanna J. Attai, MD, surgeon, president, Center For Breast Care, Burbank, CA, discusses the overdiagnosis of breast cancer.
Deanna J. Attai, MD, surgeon, president, Center For Breast Care, Burbank, CA, discusses the overdiagnosis of breast cancer.
The presentation at the 2013 Breast Cancer Symposium was particularly good, Attai says, because it looked at breast cancer diagnosis from the perspective of a pathologist, radiologist, and surgeon.
Clinical Pearls
Because breast cancer is a complicated disease, pathologists sometimes have a hard time determining between high-risk lesions and low-grade cancer, Attai says. Instead of just issuing a blanket statement that breast cancer is being overdiagnosed and overtreated, the oncology community needs to dig deeper into the definition and identification of the disease in order to individualize treatment.
- Pathologists sometimes have difficulty determining between high-risk lesions and low-grade cancer
- There is a need to dig deeper into the definition and identification of breast cancer
Batalini Explores Role of UGT1A1 in Patients Treated With Sacituzumab Govitecan for HR+ MBC
April 22nd 2024During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, discussed the TROPiCS-02 trial of sacituzumab govitecan and the impact of the UGT1A1 status on adverse event frequency.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
